Loading clinical trials...
Loading clinical trials...
This study aims to assess the natural history of Batten disease (Neuronal Ceroid Lipofuscinosis) by obtaining information about the motor, behavioral, and functional capabilities of individuals with B...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Rochester
NCT03307304 · Juvenile Neuronal Ceroid Lipofuscinosis (CLN3), Batten Disease
NCT06844877 · Neuronal Ceroid Lipofuscinosis
NCT04476862 · Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2
NCT05152914 · Neuronal Ceroid Lipofuscinosis Type 2
NCT05228145 · Neuronal Ceroid Lipofuscinosis CLN5
University of Rochester
Rochester, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions